| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M202487200 |
| P698 | PubMed publication ID | 11943784 |
| P2093 | author name string | Huasheng Lu | |
| Robert A Forbes | |||
| Ajay Verma | |||
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| carcinogenesis | Q1637543 | ||
| P304 | page(s) | 23111-23115 | |
| P577 | publication date | 2002-04-09 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis | |
| P478 | volume | 277 |
| Q37346956 | 24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development |
| Q52817283 | A Metabolic Therapy for Malignant Glioma Requires a Clinical Measure. |
| Q52576032 | A Survival Model in Locally Advanced and Metastatic Pancreatic Ductal Adenocarcinoma. |
| Q24650249 | A new view of carcinogenesis and an alternative approach to cancer therapy |
| Q30497799 | A self referencing platinum nanoparticle decorated enzyme-based microbiosensor for real time measurement of physiological glucose transport. |
| Q37533684 | ATP increases within the lumen of the endoplasmic reticulum upon intracellular Ca2+ release |
| Q34192789 | Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression |
| Q37487004 | Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. |
| Q36743904 | Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms |
| Q37281258 | Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM) |
| Q64057248 | An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases |
| Q50354089 | An example of the prisoner's dilemma in biochemistry |
| Q35679487 | Autophagy promotes paclitaxel resistance of cervical cancer cells: involvement of Warburg effect activated hypoxia-induced factor 1-α-mediated signaling |
| Q38712952 | Bardoxolone-methyl inhibits migration and metabolism in MCF7 cells |
| Q28486165 | Bioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancer |
| Q39428665 | Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation |
| Q38358785 | Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. |
| Q38335800 | Cancer metabolomics in basic science perspective. |
| Q104268676 | Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma |
| Q50034271 | Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness. |
| Q38154554 | Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases |
| Q92909900 | Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming |
| Q28585809 | Cardiac Per2 functions as novel link between fatty acid metabolism and myocardial inflammation during ischemia and reperfusion injury of the heart |
| Q45014583 | Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model |
| Q90284097 | Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism |
| Q92499916 | Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial |
| Q34203416 | Cell surface lactate receptor GPR81 is crucial for cancer cell survival |
| Q89608078 | Cell-to-cell lactate shuttle operates in heart and is important in age-related heart failure |
| Q36738269 | Central carbon metabolism in the progression of mammary carcinoma |
| Q37021691 | Changing the energy of an immune response |
| Q24338864 | Chronic CSE treatment induces the growth of normal oral keratinocytes via PDK2 upregulation, increased glycolysis and HIF1α stabilization |
| Q90699675 | Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer |
| Q57109688 | Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT |
| Q42680803 | Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders. |
| Q36266605 | Decreased VEGF expression and microvascular density, but increased HIF-1 and 2α accumulation and EPO expression in chronic moderate hyperoxia in the mouse brain |
| Q90613463 | Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism |
| Q37280649 | Development of EGFR-Targeted Polymer Blend Nanocarriers for Combination Paclitaxel/Lonidamine Delivery To Treat Multi-Drug Resistance in Human Breast and Ovarian Tumor Cells |
| Q48281174 | Diet-induced ketosis increases capillary density without altered blood flow in rat brain. |
| Q36897343 | Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved |
| Q38327525 | Dysregulated glycolysis as an oncogenic event |
| Q38697504 | E-cadherin expression increases cell proliferation by regulating energy metabolism through nuclear factor-κB in AGS cells. |
| Q38812959 | Effect of polyphenols on glucose and lactate transport by breast cancer cells. |
| Q46010223 | Effect of siRNA targeting HIF-1alpha combined L-ascorbate on biological behavior of hypoxic MiaPaCa2 cells. |
| Q46569803 | Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic mice |
| Q37593365 | Emerging evidence of the physiological role of hypoxia in mammary development and lactation |
| Q36111593 | Emerging glycolysis targeting and drug discovery from chinese medicine in cancer therapy |
| Q38096263 | Emerging roles of TRPA1 in sensation of oxidative stress and its implications in defense and danger. |
| Q40585805 | Endogenous 2-oxoacids differentially regulate expression of oxygen sensors |
| Q41102193 | Endoplasmic Reticulum Stress Sensor IRE1α Enhances IL-23 Expression by Human Dendritic Cells. |
| Q46427869 | Enhanced Aerobic Glycolysis by S-Nitrosoglutathione via HIF-1α Associated GLUT1/Aldolase A Axis in Human Endothelial Cells |
| Q40076272 | Enhanced aerobic glycolysis of nasopharyngeal carcinoma cells by Epstein-Barr virus latent membrane protein 1. |
| Q41471256 | Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer |
| Q37874709 | Enzymatic features of the glucose metabolism in tumor cells |
| Q38968841 | Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer. |
| Q26999392 | Erythropoietin: powerful protection of ischemic and post-ischemic brain |
| Q37565177 | Exogenous pyruvate facilitates cancer cell adaptation to hypoxia by serving as an oxygen surrogate. |
| Q37482653 | Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation |
| Q47612204 | Expression of Glut-1 in Malignant Melanoma and Melanocytic Nevi: an Immunohistochemical Study of 400 Cases. |
| Q24652381 | Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted |
| Q51751765 | Expressions of hypoxia-inducible factor-1α and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features. |
| Q52542413 | Extracellular Acid-Base Balance and Ion Transport Between Body Fluid Compartments. |
| Q38225316 | Extracellular acidity, a "reappreciated" trait of tumor environment driving malignancy: perspectives in diagnosis and therapy. |
| Q37060750 | Extracellular matrix metalloproteinase inducer (CD147/BSG/EMMPRIN)-induced radioresistance in cervical cancer by regulating the percentage of the cells in the G2/m phase of the cell cycle and the repair of DNA Double-strand Breaks (DSBs). |
| Q51069058 | From gametogenesis and stem cells to cancer: common metabolic themes. |
| Q34429912 | Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. |
| Q34410669 | GLUT-1 expression is largely unrelated to both hypoxia and the Warburg phenotype in squamous cell carcinomas of the vulva |
| Q40240007 | GLUT3 and PKM2 regulate OCT4 expression and support the hypoxic culture of human embryonic stem cells. |
| Q55645886 | GSEA-InContext: identifying novel and common patterns in expression experiments. |
| Q44848205 | Geldanamycin treatment inhibits hemorrhage-induced increases in KLF6 and iNOS expression in unresuscitated mouse organs: role of inducible HSP70. |
| Q36003936 | Gene expression signatures of breast cancer stem and progenitor cells do not exhibit features of Warburg metabolism |
| Q83048652 | Gene expression, autonomic function and chronic hypoxia:lessons from the Andes |
| Q64105828 | Genetic features associated with F-FDG uptake in intrahepatic cholangiocarcinoma |
| Q35722688 | Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer |
| Q33715916 | Genome-wide identification of genes involved in the positive and negative regulation of acetic acid-induced programmed cell death in Saccharomyces cerevisiae |
| Q39069327 | Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration |
| Q37125470 | Glucose metabolism as a target of histone deacetylase inhibitors. |
| Q47768925 | Glucose stimulates intestinal epithelial crypt proliferation by modulating cellular energy metabolism. |
| Q36249711 | Glucotoxicity induces glucose-6-phosphatase catalytic unit expression by acting on the interaction of HIF-1α with CREB-binding protein |
| Q64096223 | Glycolysis Regulates Human Embryonic Stem Cell Self-Renewal under Hypoxia through HIF-2α and the Glycolytic Sensors CTBPs |
| Q36516888 | Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis |
| Q24608066 | Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism |
| Q34591316 | Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. |
| Q37486782 | Guanylyl cyclase C in colorectal cancer: susceptibility gene and potential therapeutic target |
| Q38112399 | HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression |
| Q35550217 | HIF-1 as a target for drug development |
| Q36070195 | HIF-1 at the crossroads of hypoxia, inflammation, and cancer |
| Q28583933 | HIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanism |
| Q58777512 | HIF-1, Metabolism, and Diabetes in the Embryonic and Adult Heart |
| Q33790749 | HIF-1α/COX-2 expression and mouse brain capillary remodeling during prolonged moderate hypoxia and subsequent re-oxygenation |
| Q35777630 | HIF1 and oxygen sensing in the brain |
| Q27316863 | HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium |
| Q43149421 | High glucose concentrations attenuate hypoxia-inducible factor-1alpha expression and signaling in non-tumor cells |
| Q38153177 | How does cancer cell metabolism affect tumor migration and invasion? |
| Q37101209 | Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo |
| Q36653195 | Hyperbaric oxygen therapy for malignancy: a review. |
| Q34243400 | Hyperbaric oxygen, vasculogenic stem cells, and wound healing |
| Q34132735 | Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors |
| Q28579213 | Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes |
| Q34357440 | Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation |
| Q39335098 | Hypoxia upregulates CD147 through a combined effect of HIF-1α and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors. |
| Q28081811 | Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters |
| Q42426199 | Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies |
| Q27001095 | Hypoxia-inducible factor 1 and its role in viral carcinogenesis |
| Q34768392 | Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. |
| Q64058261 | Hypoxia/pseudohypoxia-mediated activation of hypoxia-inducible factor-1α in cancer |
| Q43137048 | Identification and characterization of renal cell carcinoma gene markers. |
| Q28478197 | Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer |
| Q90101108 | Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting |
| Q37694431 | Impact of Metabolism on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment |
| Q60922375 | Improving the metabolic fidelity of cancer models with a physiological cell culture medium |
| Q38857837 | Increased titer and reduced lactate accumulation in recombinant retrovirus production through the down-regulation of HIF1 and PDK. |
| Q37357824 | Inducible nitric oxide synthase (NOS-2) in subarachnoid hemorrhage: Regulatory mechanisms and therapeutic implications. |
| Q35686894 | Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells |
| Q39180889 | Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer. |
| Q45236702 | Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib). |
| Q57788714 | Iodine-125 interstitial brachytherapy reduces tumor growth via Warburg effect inhibition in non-small cell lung cancer A549 ×enografts |
| Q34213179 | Is higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized (13)C-pyruvate. |
| Q58699996 | Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma? |
| Q39442723 | Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice |
| Q37253813 | Klebsiella pneumoniae Siderophores Induce Inflammation, Bacterial Dissemination, and HIF-1α Stabilization during Pneumonia |
| Q37165231 | LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer |
| Q58701330 | LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response |
| Q55347462 | LDH-Apromotes epithelial-mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancer. |
| Q38751627 | Lactate Formation in Primary and Metastatic Colon Cancer Cells at Hypoxia and Normoxia. |
| Q21133953 | Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells |
| Q90043560 | Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect |
| Q38490731 | Lactate and cancer: revisiting the warburg effect in an era of lactate shuttling |
| Q58211884 | Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis |
| Q46678525 | Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer |
| Q28533757 | Lactate dehydrogenase 5 expression in Non-Hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis |
| Q36149654 | Lactate does not activate NF-κB in oxidative tumor cells |
| Q37175153 | Lactate engages receptor tyrosine kinases Axl, Tie2, and vascular endothelial growth factor receptor 2 to activate phosphoinositide 3-kinase/Akt and promote angiogenesis |
| Q36125255 | Lactate promotes PGE2 synthesis and gluconeogenesis in monocytes to benefit the growth of inflammation-associated colorectal tumor |
| Q36781200 | Lactate promotes glutamine uptake and metabolism in oxidative cancer cells |
| Q46269325 | Lactate stimulates CA IX expression in normoxic cancer cells. |
| Q52626044 | Lactate stimulates angiogenesis and accelerates the healing of superficial and ischemic wounds in mice. |
| Q41884316 | Lactate stimulates vasculogenic stem cells via the thioredoxin system and engages an autocrine activation loop involving hypoxia-inducible factor 1. |
| Q37547661 | Lactate, a Neglected Factor for Diabetes and Cancer Interaction. |
| Q50095883 | Lactic Acid: No Longer an Inert and End-Product of Glycolysis |
| Q36821254 | Lactic acid polarizes macrophages to a tumor-promoting state |
| Q33921642 | Low oxygen tension increases mitochondrial membrane potential and enhances expression of antioxidant genes and implantation protein of mouse blastocyst cultured in vitro |
| Q92070081 | Matrine Reverses the Warburg Effect and Suppresses Colon Cancer Cell Growth via Negatively Regulating HIF-1α |
| Q27014979 | Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells |
| Q47713737 | Melanoma tumors exhibit a variable but distinct metabolic signature. |
| Q64088355 | Metabolic Control of Dendritic Cell Functions: Digesting Information |
| Q36137196 | Metabolic Plasticity in Cancer Cells: Reconnecting Mitochondrial Function to Cancer Control |
| Q38969211 | Metabolic Regulation of Apoptosis in Cancer. |
| Q36353801 | Metabolic Reprogramming of Stem Cell Epigenetics |
| Q84040556 | Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue |
| Q38655417 | Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway |
| Q88720563 | Metabolic changes in bladder cancer |
| Q28390457 | Metabolic profiling identifies lung tumor responsiveness to erlotinib |
| Q95273444 | Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1 |
| Q40065267 | Metabolism in Immune Cell Differentiation and Function. |
| Q53438540 | Metaboloptics: Visualization of the tumor functional landscape via metabolic and vascular imaging. |
| Q39340562 | Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC. |
| Q35858632 | Methylene blue-induced neuronal protective mechanism against hypoxia-reoxygenation stress |
| Q36432405 | Microenvironments and cellular characteristics in the micro tumor cords of malignant solid tumors |
| Q38111291 | Mini-review on glycolysis and cancer |
| Q37739000 | Mitochondrial Dysfunction and Immune Cell Metabolism in Sepsis. |
| Q34746073 | Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines. |
| Q93037374 | Mitochondrial calcium uniporter regulates PGC-1α expression to mediate metabolic reprogramming in pulmonary fibrosis |
| Q37311021 | Mitochondrial mutations contribute to HIF1alpha accumulation via increased reactive oxygen species and up-regulated pyruvate dehydrogenease kinase 2 in head and neck squamous cell carcinoma |
| Q30050175 | Modeling Alveolar Soft Part Sarcomagenesis in the Mouse: A Role for Lactate in the Tumor Microenvironment |
| Q34082747 | Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems. |
| Q38800932 | Modulation of the uptake of critical nutrients by breast cancer cells by lactate: Impact on cell survival, proliferation and migration |
| Q92506650 | Monocarboxylate transporters in cancer |
| Q37187094 | Monocarboxylate transporters in the brain and in cancer. |
| Q35136562 | Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology |
| Q91711304 | Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers |
| Q28594703 | Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice |
| Q34762667 | Multisite Kinetic Modeling of (13)C Metabolic MR Using [1-(13)C]Pyruvate |
| Q42181499 | Nanomaterial based self-referencing microbiosensors for cell and tissue physiology research |
| Q34009713 | Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1) |
| Q47160346 | Non-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer |
| Q36378405 | Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1α-dependent function |
| Q39938298 | Normoxic accumulation of HIF1α is associated with glutaminolysis |
| Q46445817 | Oligomycin inhibits HIF-1alpha expression in hypoxic tumor cells |
| Q34498003 | On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate. |
| Q37395416 | Oncogene-directed alterations in cancer cell metabolism |
| Q55457391 | Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas. |
| Q26749333 | Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction |
| Q34297526 | Overexpression of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase A in nerve cells confers resistance to amyloid β and other toxins by decreasing mitochondrial respiration and reactive oxygen species production. |
| Q37845832 | Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors |
| Q39210001 | PDK1 inhibition is a novel therapeutic target in multiple myeloma |
| Q92859864 | PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension |
| Q58792258 | PI3K/Akt and HIF‑1 signaling pathway in hypoxia‑ischemia (Review) |
| Q58741231 | PKM2 and HIF-1α regulation in prostate cancer cell lines |
| Q33771214 | Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements |
| Q40295842 | Phospholipase D couples survival and migration signals in stress response of human cancer cells |
| Q40643080 | Phyllanthus Suppresses Prostate Cancer Cell, PC-3, Proliferation and Induces Apoptosis through Multiple Signalling Pathways (MAPKs, PI3K/Akt, NFκB, and Hypoxia). |
| Q26766128 | Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development |
| Q37636819 | Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia |
| Q34891746 | Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds |
| Q37148936 | Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer |
| Q89907600 | Prognostic Values of LDH and CRP in Cervical Cancer |
| Q64099936 | Prognostic Values of Systemic Inflammation Response (SIR) Parameters in Resectable Cervical Cancer |
| Q61456291 | Prognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters |
| Q37089504 | Protein profiles associated with survival in lung adenocarcinoma |
| Q33237312 | Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. |
| Q36460635 | Pyruvate Dehydrogenase Kinases in the Nervous System: Their Principal Functions in Neuronal-glial Metabolic Interaction and Neuro-metabolic Disorders |
| Q53567876 | Pyruvate Is Superior to Citrate in Oral Rehydration Solution in the Protection of Intestine via Hypoxia-Inducible Factor-1 Activation in Rats With Burn Injury. |
| Q41460387 | Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma |
| Q24320179 | Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells |
| Q50507655 | Pyruvate effects on red blood cells during in vitro cardiopulmonary bypass with dogs' blood. |
| Q52563096 | Pyruvate is a prospective alkalizer to correct hypoxic lactic acidosis. |
| Q40080523 | Pyruvate reduces DNA damage during hypoxia and after reoxygenation in hepatocellular carcinoma cells |
| Q55462757 | RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival. |
| Q37181226 | Redox regulation of cell survival |
| Q28077883 | Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effect |
| Q38082722 | Regulation and dysregulation of astrocyte activation and implications in tumor formation |
| Q34594985 | Regulation of the Warburg effect in early-passage breast cancer cells. |
| Q38248551 | Regulation of vascular endothelial growth factor by metabolic context of the cell. |
| Q64244272 | Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma |
| Q34344477 | Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme |
| Q40362310 | Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. |
| Q37901922 | Revisiting the TCA cycle: signaling to tumor formation |
| Q37079729 | Role and regulation of prolyl hydroxylase domain proteins |
| Q34610733 | Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning |
| Q37992508 | Role of monocarboxylate transporters in human cancers: state of the art. |
| Q24328747 | SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation |
| Q33310747 | Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients |
| Q50050739 | Silencing of NADPH oxidase 4 attenuates hypoxia resistance in neuroblastoma cells SHSY-5Y by inhibiting PI3K/Akt-dependent glycolysis |
| Q39643937 | Sirtuin 1-dependent resveratrol cytotoxicity and pro-differentiation activity on breast cancer cells. |
| Q39047704 | Sirtuin 6 attenuates periapical lesion propagation by modulating hypoxia-induced chemokine (C-C motif) ligand 2 production in osteoblasts |
| Q45857447 | Sirtuin 6 suppresses hypoxia-induced inflammatory response in human osteoblasts via inhibition of reactive oxygen species production and glycolysis-A therapeutic implication in inflammatory bone resorption. |
| Q28283920 | Splice isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4: expression and hypoxic regulation |
| Q33676302 | Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α. |
| Q52609135 | Synaptic activity-induced glycolysis facilitates membrane lipid provision and neurite outgrowth. |
| Q33668662 | TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization |
| Q48256237 | TMEM207 hinders the tumour suppressor function of WWOX in oral squamous cell carcinoma |
| Q26738876 | Targeting Cancer Metabolism - Revisiting the Warburg Effects |
| Q92634010 | Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic Compounds |
| Q38133722 | Targeting lactate metabolism for cancer therapeutics |
| Q36326353 | Targeting lactate transport suppresses in vivo breast tumour growth |
| Q38640439 | Targeting metabolic pathways for head and neck cancers therapeutics. |
| Q37452112 | Targeting metabolic plasticity in breast cancer cells via mitochondrial complex I modulation. |
| Q34200930 | Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. |
| Q50954228 | Targeting thiamine-dependent enzymes for metabolic therapies in oral squamous cell carcinoma? |
| Q48308048 | Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies |
| Q33840307 | The Drosophila mitochondrial ribosomal protein mRpL12 is required for Cyclin D/Cdk4-driven growth |
| Q38818962 | The Effect of Silencing HIF-1α Gene in BxPC-3 Cell Line on Glycolysis-Related Gene Expression, Cell Growth, Invasion, and Apoptosis |
| Q42367956 | The Linkage between Breast Cancer, Hypoxia, and Adipose Tissue |
| Q33872257 | The MARCH family E3 ubiquitin ligase K5 alters monocyte metabolism and proliferation through receptor tyrosine kinase modulation |
| Q37628732 | The anti-oxidant capacity of tumour glycolysis |
| Q34534959 | The clinicopathologic importance of serum lactic dehydrogenase in patients with gastric cancer |
| Q40245561 | The development and characterization of an HEK293-derived cell line for use in an intratumoral cytokine delivery system |
| Q42028167 | The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis |
| Q28079015 | The ever-expanding role of HIF in tumour and stromal biology |
| Q36557422 | The expression pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells |
| Q28588941 | The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha |
| Q34376363 | The hypoxia-inducible factor and tumor progression along the angiogenic pathway. |
| Q35012840 | The hypoxic core: a possible answer to the cancer paradox |
| Q48181172 | The hypoxic tumour microenvironment |
| Q38991057 | The immune system's role in sepsis progression, resolution, and long-term outcome |
| Q34801576 | The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages. |
| Q37982890 | The pyruvate dehydrogenase complex as a therapeutic target for age-related diseases |
| Q42174809 | The role of glucose metabolism and glucose-associated signalling in cancer. |
| Q38234184 | The role of ¹⁸F-FDG PET imaging in upper gastrointestinal malignancies |
| Q47282821 | Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process |
| Q33748280 | Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma |
| Q90633242 | Transcriptional Regulation of Energy Metabolism in Cancer Cells |
| Q38149945 | Transcriptional regulation by hypoxia inducible factors |
| Q35618203 | Transient elevation of glycolysis confers radio-resistance by facilitating DNA repair in cells |
| Q34043101 | Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation |
| Q40132752 | Tumor Necrosis Factor-alpha- and interleukin-1-induced cellular responses: coupling proteomic and genomic information |
| Q50949228 | Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells. |
| Q35602696 | Tumor hypoxia: a target for selective cancer therapy |
| Q35202899 | Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. |
| Q37727266 | Varying postresection lactate dehydrogenase with overall survival of early stage pancreatic cancer patients: A retrospective study |
| Q90313729 | Warburg and Krebs and related effects in cancer |
| Q41812521 | Warburg revisited: lessons for innate immunity and sepsis |
| Q36065049 | Warburg-like Glycolysis and Lactate Shuttle in Mouse Decidua during Early Pregnancy |
| Q35182579 | What can ecology teach us about cancer? |
| Q28290710 | Why do cancers have high aerobic glycolysis? |
| Q38995243 | Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer |
| Q46791877 | Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway |
| Q83164703 | [High intensity training (HIT) for the improvement of endurance capacity of recreationally active people and in prevention & rehabilitation] |
| Q55464206 | [Mechanism of Warburg effect and its effect on tumor metastasis]. |
| Q52337206 | [The Warburg effect: from theory to therapeutic applications in cancer]. |
| Q34231591 | mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3 |
| Q41676741 | microRNA and Wound Healing |
| Q55002919 | p53 and metabolism: from mechanism to therapeutics. |
| Q36250650 | pH, Lactate, and Hypoxia: Reciprocity in Regulating High-Affinity Monocarboxylate Transporter Expression in Glioblastoma |
Search more.